- True Leaf (MJ) has signed an agreement for exclusive rights to Cold Plasma Group’s organic cannabis anti-microbial technology in B.C.
- Cold Plasma Group’s technology uses oxygen-enriched plasma to disinfect cannabis flower, obviating the need for most pesticides
- The company believes the agreement will lead to increased consumer confidence and the ability to command a higher price per gram
- True Leaf is a licensed cannabis producer preparing to launch a program to provide seed-to-shelf solutions for micro-cultivators
- True Leaf (MJ) closed the day down 7.5 per cent trading at $0.37 per share
True Leaf (MJ) has signed an agreement for exclusive rights to Cold Plasma Group’s organic cannabis anti-microbial technology in B.C.
With Health Canada’s stringent safety requirements, many licensed cannabis producers use irradiation to ensure their products are contaminant-free.
True Leaf believes irradiation may alter the moisture content, texture, colour, cannabinoids, odour and terpene profiles of the product.
A B.C. government study released last week also shows representative samples of unregulated cannabis tainted with 24 pesticides and unacceptable levels of bacteria, fungi, lead and arsenic.
Cold Plasma Group’s technology uses oxygen-enriched plasma to disinfect the cannabis flower without degrading quality, physical characteristics or terpene profiles, obviating the need for most pesticides.
True Leaf management believes the agreement will lead to increased consumer confidence in its products, increased marketing appeal and the ability to command a higher price per gram.
The memorandum of understanding anticipates a joint venture agreement and share purchase option agreement on or before July 31, 2021.
Darcy Bomford, True Leaf’s CEO, commented,
“Our mission is to bring higher quality craft cannabis to consumers. We believe CPG’s technology will provide microbial-free cannabis with no product degradation, and we look forward to offering this service to our micro-cultivator clients.”
David Johnson, President of Cold Plasma Group, added,
“We are proud to partner with an innovator like True Leaf which is also committed to elevating Canada’s cannabis industry with higher quality products. Many consumers feel the irradiation process in cannabis causes damage to the product by creating a reduction in terpenes, altering flavour and effect. The demand for non-irradiated cannabis is huge and we look forward to working with True Leaf to meet consumer demand.”
True Leaf is a licensed cannabis producer preparing to launch a program to provide seed-to-shelf solutions for micro-cultivators.
True Leaf (MJ) closed the day down 7.5 per cent trading at $0.37 per share.
